RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 6,950.00
-70.00 (-1.00%)
At close: Sep 19, 2025
RP Bio Market Cap
RP Bio has a market cap or net worth of 60.23 billion as of September 19, 2025. Its market cap has decreased by -3.07% in one year.
Market Cap
60.23B
Enterprise Value
66.05B
Revenue
129.09B
Ranking
n/a
PE Ratio
19.79
Stock Price
6,950.00
Market Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 60.23B, a decrease of -57.93%. That is a compound annual growth rate of -25.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 60.23B | 37.62% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
| Sep 29, 2022 | 143.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 520.34T |
| SK hynix | 243.72T |
| LG Energy Solution | 81.78T |
| Samsung Biologics | 72.88T |
| Hanwha Aerospace | 52.58T |
| Hyundai Motor Company | 46.74T |
| HD Hyundai Heavy Industries | 43.77T |
| KB Financial Group | 42.42T |